Kiyonori Tanoue
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 27, 2025
Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Adenocarcinoma.Ryu Matsumoto, Kiyonori Tanoue, Chieri Nakayama
|Mar 04, 2025
RBBP8 Is a Prognostic Biomarker Associated With Response to Immune Checkpoint Inhibitors in Advanced Gastric Cancer.Taiki Nakashima, Ryu Matsumoto, Kiyonori Tanoue
|Dec 17, 2024
The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer.Yuki Hamada, Kiyonori Tanoue, Takaaki Arigami
|Mar 29, 2023
Vascular endothelial growth factor inhibitors promote antitumor responses via tumor microenvironment immunosuppression in advanced colorectal cancer.Yuki Hamada, Kiyonori Tanoue, Yoshiaki Kita
|Jan 10, 2022
Multidisciplinary treatment of advanced or recurrent solid pseudopapillary neoplasm of the pancreas: three case reports.Kiyonori Tanoue, Yuko Mataki, Hiroshi Kurahara
|Dec 17, 2021
Postoperative recurrence with right cervical lymph node metastasis in hepatocellular carcinoma: a case report.Kiyonori Tanoue, Yota Kawasaki, Yoichi Yamasaki
Pageof 1
